Navigation Links
OSStaple™ Dynamic Compression Staple

ProductsOSStaple™ Dynamic Compression Staple
Company Biomedical Enterprises
Item OSStaple™ Dynamic Compression Staple
Features 
  • Utilizes an electrical heating controlled shape memory phenomenon
  • Only product of this type in the U.S. market
  • Used for fracture fixation or arthrodesis in the hand, foot and ankle, repair of oral/maxillofacial fractures, general fracture fragment fixation, skull and also for ligament reattachment
  • Faster bone healing
  • Distributed with a 12-component instrument set which includes an electronic current source that is safety and quality approved for BME by Underwriter Laboratories
  • Description OSStaple™ Dynamic Compression Staple is a novel shape memory alloy bone staple and plate formed from Nitinol alloy. Because of its Nitinol construction, the prongs of the staple can be made to deflect in bone upon application of a heating current. This results in the unique ability to speed the healing response of bone and cause adjustable compression across the fracture or fusion site during surgery as is demonstrated below:
    Info Biomedical Enterprises
    Customer Service: (800) 880-6528
    Web site: http://www.bme-tx.com/

    Related medicine products :

    1. SB Charit Intervertebral Dynamic Disc Spacer
    2. PASCAL Dynamic Contour Tonometer
    3. Xtrem Dynamic electrophysiology catheter
    4. DJD II Dynamic Elbow Joint Distractor
    5. Procyon P2000SA Dynamic Binocular Pupillometer
    6. The PASCAL Dynamic Contour Tonometer
    7. Ossur® AFO Dynamic
    8. Comfy™ Dynamic Elbow Torque Orthosis
    9. BODI™ Dynamic Orthosis
    10. Controlled Dynamic Stretch Knee Brace
    11. syngoDynamics
    ... an innovative handheld device for ... non-invasively, comfortably, and accurately.,It is, ... than an automatic blood pressure ... charge, Vasotrax will take approximately ...
    ... Insulin-like growth factor II (IGF-II) is a 7.5 ... liver and is postulated to have mitogenic and ... of IGF-II are mediated by binding to target ... the Type II IGF receptor, a monomeric protein ...
    ... Pregnancy-associated plasma protein A (PAPP-A) is ... is produced in high concentrations by ... into the maternal circulation in increasing ... PAPP-A is not specific to pregnancy ...
    ... Pregnancy-associated plasma protein A (PAPP-A) ... PAPP-A is produced in high concentrations ... released into the maternal circulation in ... [1]. PAPP-A is not specific to ...
    Medicine Products:
    (Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
    (Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
    (Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
    (Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
    (Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
    Breaking Medicine News(10 mins):
    (Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
    (Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
    (Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
    Breaking Medicine Technology: